fbpx

RLR Volume I Issue II

‘… Pigs Fly’ – The Validity Of Gene Patenting Vis A Vis The Myriad And Novartis Patent Case

“Undue difficulty in gaining patent protection will deter investment by reducing the prospect of a reasonable return. This is not in the interests of patients, or of industry. On the other hand, too free availability and excessive breadth of protection will give undue reward for prosaic contribution and may inhibit the speed of exchange of […]

‘… Pigs Fly’ – The Validity Of Gene Patenting Vis A Vis The Myriad And Novartis Patent Case Read More »

Scroll to Top